Abstract
Keratoprosthesis design, surgery, and clinical management have undergone tremendous advancement over the past century [1]. Its modern-day use represents an important treatment for corneal blindness in conditions not amenable to traditional penetrating keratoplasty (PKP) [2]. While actual keratoprosthesis placement is traditionally done by a cornea specialist, the vitreoretinal specialist plays an important role in the preoperative, intraoperative, and postoperative management of keratoprosthesis patients [3, 4]. Although many types of keratoprostheses, or KPros, are in modern-day use worldwide, including the osteo-odonto-keratprosthesis (OOKP) [5], this chapter will focus on the Boston keratoprosthesis [6], one of the most widely used KPros in the world.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Liu C, Hille K, Tan D, Hicks C, Herold J. Keratoprosthesis surgery. Dev Ophthalmol. 2008;41:171–86.
Klufas MA, Colby KA. The Boston keratoprosthesis. Int Ophthalmol Clin. 2010;50(3):161–75.
Ray S, Khan BF, Dohlman CH, D’Amico DJ. Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol. 2002;120(5):559–66.
Kiang L, Sippel KC, Starr CE, et al. Vitreoretinal surgery in the setting of permanent keratoprosthesis. Arch Ophthalmol. 2012;130(4):487–92.
Liu C, Paul B, Tandon R, et al. The osteo-odonto-keratoprosthesis (OOKP). Semin Ophthalmol. 2005;20(2):113–28.
Traish AS, Chodosh J. Expanding application of the Boston type I keratoprosthesis due to advances in design and improved post-operative therapeutic strategies. Semin Ophthalmol. 2010;25(5-6):239–43.
Dohlman CH, Doane MG. Some factors influencing outcome after keratoprosthesis surgery. Cornea. 1994;13(3):214–8.
Dohlman CH, Harissi-Dagher M, Khan BF, Sippel K, Aquavella JV, Graney JM. Introduction to the use of the Boston keratoprosthesis. Expert Rev Ophthalmol. 2006;1(1):41–8.
Harissi-Dagher M, Durr GM, Biernacki K, Sebag M, Rheaume MA. Pars plana vitrectomy through the Boston keratoprosthesis type 1. Eye (Lond). 2013;27(6):767–9.
Georgalas I, Kanelopoulos AJ, Petrou P, Ladas I, Gotzaridis E. Presumed endophthalmitis following Boston keratoprosthesis treated with 25 gauge vitrectomy: a report of three cases. Graefes Arch Clin Exp Ophthalmol. 2010;248(3):447–50.
Dohlman C, Harissi-Dagher M. The Boston keratoprosthesis: a new threadless design. Digit J Opthalmol. 2007;13(3).
Sayegh RR, Dohlman CH. Wide-angle fundus imaging through the Boston keratoprosthesis. Retina. 2013;33(6):1188–92.
Goldman DR, Hubschman JP, Aldave AJ, et al. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis. Retina. 2013;33(3):532–41.
Robert MC, Biernacki K, Harissi-Dagher M. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers. Cornea. 2012;31(4):339–45.
Robert MC, Harissi-Dagher M. Boston type 1 keratoprosthesis: the CHUM experience. Can J Ophthalmol. 2011;46(2):164–8.
Kamyar R, Weizer JS, de Paula FH, et al. Glaucoma associated with Boston type I keratoprosthesis. Cornea. 2012;31(2):134–9.
Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology. 2011;118(8):1543–50.
Chew HF, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea. 2009;28(9):989–96.
Aquavella JV, Qian Y, McCormick GJ, Palakuru JR. Keratoprosthesis: current techniques. Cornea. 2006;25(6):656–62.
Rudnisky CJ, Belin MW, Todani A, et al. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Ophthalmology. 2012;119:951.
Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116(4):640–51.
Patel AP, Wu EI, Ritterband DC, Seedor JA. Boston type 1 keratoprosthesis: the New York eye and ear experience. Eye (Lond). 2012;26(3):418–25.
Chak G, Aquavella JV. A safe Nd:YAG retroprosthetic membrane removal technique for keratoprosthesis. Cornea. 2010;29(10):1169–72.
Stacy RC, Jakobiec FA, Michaud NA, Dohlman CH, Colby KA. Characterization of retrokeratoprosthetic membranes in the Boston type 1 keratoprosthesis. Arch Ophthalmol. 2011;129(3):310–6.
Huang Y, Yu J, Liu L, Du G, Song J, Guo H. Moscow eye microsurgery complex in Russia keratoprosthesis in Beijing. Ophthalmology. 2011;118(1):41–6.
Ciolino JB, Belin MW, Todani A, Al-Arfaj K, Rudnisky CJ. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology. 2013;120(6):1195–200.
Dokey A, Ramulu PY, Utine CA, et al. Chronic hypotony associated with the Boston type 1 keratoprosthesis. Am J Ophthalmol. 2012;154(2):266–71 e261.
Nouri M, Terada H, Alfonso EC, Foster CS, Durand ML, Dohlman CH. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol. 2001;119(4):484–9.
Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea. 2009;28(8):896–901.
Chan CC, Holland EJ. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation. Cornea. 2012;31(4):346–9.
Ramchandran RS, Diloreto Jr DA, Chung MM, et al. Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis. Ophthalmology. 2012;119(4):674–81.
Rai R, Shorter E, Cortina MS, McMahon T, de la Cruz J. Contact lens surveillance cultures in Boston type 1 keratoprosthesis patients. Eye Contact Lens. 2013;39(2):175–8.
Barnes SD, Dohlman CH, Durand ML. Fungal colonization and infection in Boston keratoprosthesis. Cornea. 2007;26(1):9–15.
Aldave AJ, Sangwan VS, Basu S, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. 2012;119(8):1530–8.
Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol. 2012;96(6):776–80.
Sayegh RR, Ang LP, Foster CS, Dohlman CH. The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol. 2008;145(3):438–44.
Netland PA, Terada H, Dohlman CH. Glaucoma associated with keratoprosthesis. Ophthalmology. 1998;105(4):751–7.
Bradley JC, Hernandez EG, Schwab IR, Mannis MJ. Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea. 2009;28(3):321–7.
Iyer G, Pillai VS, Srinivasan B, et al. Modified osteo-odonto keratoprosthesis – the Indian experience – results of the first 50 cases. Cornea. 2010;29(7):771–6.
Nouri M, Durand ML, Dohlman CH. Sudden reversible vitritis after keratoprosthesis: an immune phenomenon? Cornea. 2005;24(8):915–9.
Huang Y, Dong Y, Wang L, et al. Long-term outcomes of MICOF keratoprosthesis in the end stage of autoimmune dry eyes: an experience in China. Br J Ophthalmol. 2012;96(1):28–33.
Yu J, Huang Y, Song J, Wang L, Wang F. Keratoprosthesis sterile vitritis. Ophthalmology. 2011;118(1):221.
Dunlap K, Chak G, Aquavella JV, Myrowitz E, Utine CA, Akpek E. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation. Ophthalmology. 2010;117(4):687–92.
Zerbe BL, Belin MW, Ciolino JB. Results from the multicenter Boston type 1 keratoprosthesis study. Ophthalmology. 2006;113(10):1779 e1771–7.
Khan BF, Harissi-Dagher M, Khan DM, Dohlman CH. Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin. 2007;47(2):61–71.
D’Amico DJ. New methods for retinal examination in eyes with a Boston keratoprosthesis. Retina. 2013;33(6):1097–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Klufas, M.A., D’Amico, D.J., Kiss, S. (2015). Vitreoretinal Considerations in the Setting of the Permanent Keratoprosthesis. In: Patelli, F., Rizzo, S. (eds) Management of Complicated Vitreoretinal Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-17208-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-17208-8_12
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17207-1
Online ISBN: 978-3-319-17208-8
eBook Packages: MedicineMedicine (R0)